Navigation Links
Stiefel Laboratories Appoints Two New Members to Board of Directors
Date:9/21/2007

Private equity investor The Blackstone Group now represented on company's

board

CORAL GABLES, Fla., Sept. 21 /PRNewswire/ -- Stiefel Laboratories, Inc. today announced the appointment of two new members to the company's board of directors. The appointments include a representative of the private equity firm The Blackstone Group, which recently became a minority-share investor in the company.

Joining the board are Lodewijk J.R. de Vink, a founding member of Blackstone Healthcare Partners LLP (BHP), and Jeffrey S. Thompson, chief operating officer for Stiefel Laboratories.

Charles W. Stiefel is president, chief executive officer and chairman of Stiefel Laboratories.

"I am pleased to welcome Jeff and Lodewijk to the board at this exciting time," Stiefel said. "Their appointments strengthen our board and thus our company. I am confident they will complement the team as our company continues to grow."

Blackstone's $500 million investment in Stiefel Laboratories, a deal which closed August 10, includes the right to designate one member on the company's board of directors.

Lodewijk de Vink has more than 40 years experience in the pharmaceutical and healthcare industries. In addition to working for such companies as Schering-Plough, Credit Suisse First Boston and Warner-Lambert Company as chairman and CEO, de Vink has been a consultant with Blackstone since 2003 and currently sits on several boards including Roche and Alcon.

"An important aspect of our relationship with Blackstone," Stiefel said, "is the ability to leverage its resources and experience. I look forward to working with Lodewijk not only because of his warm persona, but because of the unparalleled experience he brings to the board."

Jeffrey S. Thompson, COO, Stiefel Laboratories, also joins the board. Thompson, who is responsible for operations on a global level including corporate administration, facilities management, supply chain and technical operations, information technology, human resources, legal, quality and corporate compliance, plays a key role in the integration of the company's U.S. and international business. Previously, Thompson served as the President of Glades Pharmaceuticals, a wholly-owned subsidiary of Stiefel.

"Throughout his career at Stiefel Laboratories, Jeff has impressed us with his energy, enthusiasm and vast knowledge of the pharmaceutical industry," Stiefel said. "He was an instrumental part of the recent Connetics acquisition, spending several months living in Palo Alto, Calif. and serving as the on-site integration leader. His management skills have contributed to the organization's growth and success internationally and we know he will be a valuable addition to the board."

The Stiefel Laboratories board of directors also includes: William D. (Bill) Humphries, chief commercial officer; Richard MacKay, president, Stiefel Canada, Inc. and vice chairman of the board; Gabriel McGlynn, senior vice president of EURASIA; Brent Stiefel, executive vice president, global corporate development and product portfolio; Catherine Stiefel, certified public accountant, mergers & acquisitions; and Todd Stiefel, executive vice president, global strategy.

About Stiefel Laboratories, Inc.

Founded in 1847, Stiefel Laboratories (a privately held company) is the world's largest independent pharmaceutical company specializing in dermatology. The company manufactures and markets a variety of prescription and non-prescription dermatological products. Some of the newest and best- known brands include Duac(R) Topical Gel (clindamycin, 1% - benzoyl peroxide, 5%); Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; Verdeso(TM) (desonide) Foam, 0.05%; Brevoxyl(R) Creamy Wash (benzoyl peroxide, 4% or 8%) packaged in the convenient new Brevoxyl Acne Wash Kit; Oilatum(R); Physiogel(R); Stieprox(R) (ciclopirox olamine); and Sarna(R). Its wholly-owned global network is comprised of more than 30 subsidiaries, manufacturing plants in six countries, research and development facilities on four continents, and products marketed in more than 100 countries around the world.

Stiefel Laboratories supplements its R&D efforts by seeking strategic partnerships and acquisitions around the world. To learn more about Stiefel Laboratories, Inc. visit http://www.stiefel.com.


'/>"/>
SOURCE Stiefel Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. Distance-Learning Remote Laboratories using LabVIEW
3. States are the best laboratories for healthcare reform
4. Scientific Protein Laboratories Acquired by New York firm
5. Sharon Ethanol appoints operations director
6. Kyron appoints former AMA chairman to board
7. Brady appoints GE efficiency expert as CTO
8. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
9. Johnson Controls appoints Roell to head EOC
10. SecurePipe appoints two senior execs
11. Milwaukees PointOne appoints new president and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Energetiq Technology, a world leader ... expansion to accommodate its rapid growth. , The renovations at the company’s headquarters ... the existing areas. The expansion includes, a state-of-the-art engineering facility, and a second ...
(Date:5/23/2017)... Boston, Massachusetts (PRWEB) , ... May 23, 2017 , ... ... is making a splash at this year’s Bio-IT World Conference and Expo ... Anzo Smart Data Lake® 4.0 solution. The Anzo Smart Data Lake is also ...
(Date:5/22/2017)... Maryland (PRWEB) , ... May 22, 2017 , ... ... Olsen, joined with other leaders of the Maryland Biohealth community in developing and ... globally recognized Top 3 U.S. BioHealth Innovation Hub by 2023. ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... ... that helps avoid the lengthy trial and error process by finding the right ... It can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
Breaking Biology Technology:
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
Breaking Biology News(10 mins):